Unknown

Dataset Information

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.


ABSTRACT:

Background and aims

Hepatic cholesterol deposition drives inflammation and fibrosis in non-alcoholic steatohepatitis (NASH). The Niemann-Pick type C2 (NPC2) protein plays an important role in regulating intracellular cholesterol trafficking and homeostasis. We hypothesized that intravenous NPC2 supplementation reduces cholesterol accumulation, hepatic inflammation and fibrogenesis in a nutritional NASH rat model.

Methods

Rats were fed a high-fat, high-cholesterol (HFHC) diet for four weeks resulting in moderately severe NASH. Animals were treated with intravenous NPC2 or placebo twice weekly for either the last two weeks or the entire four weeks. End-points were liver/body- and spleen/body weight ratios, histopathological NASH scores, fibrosis, serum liver enzymes, cholester

SUBMITTER: Christensen CU 

PROVIDER: S-EPMC5844539 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature